InnovationNews

Atal Incubation Centre – Centre for Cellular and Molecular Biology signs agreement with Thermo Fisher Scientific

The cutting-edge technology will enable scientists in start-ups with opportunities to enhance their expertise and entrepreneurial acumen

The Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB), a premier bio-incubator in Hyderabad, has signed an agreement with Thermo Fisher Scientific. The agreement includes equipping AIC-CCMB’s state-of-the-art facility, the Centre for Innovation, with cutting-edge technology to enable scientists in start-ups with opportunities to enhance their expertise and entrepreneurial acumen.

Dr Madhusudhana Rao, CEO, AIC-CCMB said, “As one of the largest facilities supporting start-ups in healthcare, pharmaceuticals and biotechnology, AIC-CCMB endeavors to build an ecosystem that fosters innovation. Through our agreement with Thermo Fisher Scientific, we are enabling startups to drive research initiatives and reduce time-to-market for new products.”

Thermo Fisher has equipped this Centre for Innovation with state-of-the-art platforms such as CellInsight CX7 LZR Pro High Content Screening Platform, KingFisher Flex automated nucleic purification system, EVOSTM M7000 imaging system as well as laboratory freezers and refrigerators, and thermal cyclers. These tools will help scientists in research, drug discovery and assay development to support molecular biology, protein biology, cell biology and cell analysis workflows.

“The Government of India’s flagship initiatives such as the Atal Innovation Mission (AIM), are aimed at fostering an ecosystem of innovation and entrepreneurship. We are proud to work with the various bio-incubators to set up these Centres for Innovation as a part of our nationwide efforts to support innovative startups in becoming scalable and sustainable,” stated Srinath Venkatesh, MD, India & South Asia, Thermo Fisher Scientific.

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
IndiaMedToday
Close
Close